| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/16/2019 | Telemynd, Inc. | | Other (acquisition) | Common Stock | 1.1M | $0.00 | $0 | | 07/16/2019 |
| 07/16/2019 | Telemynd, Inc. | | Other (acquisition) | Series A Preferred Stock | 1000k | $0.00 | $0 | | 07/16/2019 |
| 05/23/2019 | Emmaus Life Sciences, Inc. | MYND | Purchase | COMMON STOCK | 200k | $1.25 | $250.8k | | 05/23/2019 |
| 03/14/2019 | Emmaus Life Sciences, Inc. | MYND | Purchase | COMMON STOCK | 100k | $1.68 | $167.6k | | 03/14/2019 |
| 01/31/2019 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 1000k | $0.23 | $230k | | 01/31/2019 |
| 01/14/2019 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 1000k | $0.23 | $225k | | 01/14/2019 |
| 10/08/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | COMMON STOCK | 30k | $1.38 | $41.4k | | 10/08/2018 |
| 09/24/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | | 135.1k | $1.85 | $250k | | 09/24/2018 |
| 09/24/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Common Stock Purchase Warrant | 135.1k | $2.00 | $270.3k | | 09/24/2018 |
| 08/28/2018 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 50k | $1.62 | $81k | | 08/28/2018 |
| 08/28/2018 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 50k | $1.63 | $81.5k | | 08/28/2018 |
| 08/28/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Common Stock | 50k | $1.62 | $81k | | 08/28/2018 |
| 08/28/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Common Stock | 50k | $1.63 | $81.5k | | 08/28/2018 |
| 05/25/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Common Stock | 4.5k | $2.27 | $10.2k | | 05/25/2018 |
| 03/29/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Series A Preferred Stock | 500k | $937,500.00 | $468750M | | 03/29/2018 |
| 03/29/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Series A Preferred Stock | 500k | $937,500.00 | $468750M | See Footnote | 03/29/2018 |
| 03/29/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Warrant | 500k | $62,500.00 | $31250M | | 03/29/2018 |
| 03/29/2018 | Emmaus Life Sciences, Inc. | MYND | Grant | Warrant | 500k | $62,500.00 | $31250M | See Footnote | 03/29/2018 |
| 01/05/2018 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 10k | $3.44 | $34.4k | | 01/05/2018 |
| 12/08/2017 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 150k | $1.86 | $279k | | 12/08/2017 |
| 09/28/2017 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 2.5k | $0.00 | $0 | | 09/28/2017 |
| 09/28/2017 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 5k | $2.75 | $13.8k | | 09/28/2017 |
| 09/19/2017 | Emmaus Life Sciences, Inc. | MYND | Grant | Common Stock | 12k | $0.00 | $0 | | 09/19/2017 |
| 09/19/2017 | Emmaus Life Sciences, Inc. | MYND | Grant | Director Stock Option (right to buy) | 12k | $3.60 | $43.2k | | 09/19/2017 |
| 08/18/2017 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 20k | $3.28 | $65.6k | | 08/17/2017 |
| 08/17/2017 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 66.2k | $3.24 | $214.1k | | 08/17/2017 |
| 08/17/2017 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 66.2k | $3.24 | $214.1k | | 08/17/2017 |
| 08/17/2017 | Vyant Bio, Inc. | CGIX | Purchase | Common Stock, par value $0.0001 per share | 20k | $3.28 | $65.6k | | 08/17/2017 |
| 08/09/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $3.34 | $16.7k | | 08/09/2017 |
| 08/02/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $3.65 | $18.2k | | 08/02/2017 |
| 07/25/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $4.00 | $20k | | 07/25/2017 |
| 07/21/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $4.30 | $21.5k | | 07/21/2017 |
| 07/21/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $4.20 | $21k | | 07/21/2017 |
| 07/18/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $4.54 | $22.7k | | 07/17/2017 |
| 07/17/2017 | Emmaus Life Sciences, Inc. | MYND | Purchase | Common Stock | 5k | $4.40 | $22k | | 07/17/2017 |
|